---
schema_version: "secwatch.filing_event.v1"
accession: "0001384101-24-000051"
form_type: "8-K/A"
ticker: "VCYT"
cik: "0001384101"
company_name: "VERACYTE, INC."
filed_at: "2024-04-17T23:59:59+00:00"
generated_at: "2026-06-03T21:35:33.692599+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Veracyte completes C2i acquisition for up to $95M stock; C2i had $36M loss, $78.6M debt

## Summary
- Acquisition closed Feb 5, 2024; total consideration up to $95M in Veracyte common stock.
- C2i 2023 revenue $456k, net loss $36.0M, R&D expense $17.9M, operating loss $21.9M.
- C2i had $78.6M in convertible promissory notes, $18.8M cash, $76.1M accumulated deficit as of Dec 31, 2023.
- Veracyte files audited C2i financials and unaudited pro forma combined statements to satisfy SEC requirements.

## SEC filing metadata
- accession: 0001384101-24-000051
- form_type: 8-K/A
- ticker: VCYT
- cik: 0001384101
- company_name: VERACYTE, INC.
- filed_at: 2024-04-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1384101/000138410124000051/0001384101-24-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1384101/000138410124000051/vcyt-20240205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001384101-24-000051
- JSON: https://secwatch.observer/filing/0001384101-24-000051.json
- Plain text: https://secwatch.observer/filing/0001384101-24-000051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.